View of Pathogenetic mechanisms of changes in activity of inflammation and fibrogenesis in patients with chronic diffuse liver disease after combined use perfluorocarbon emulsions and multipotent mesenchymal stromal cells

Return to Article Details Pathogenetic mechanisms of changes in activity of inflammation and fibrogenesis in patients with chronic diffuse liver disease after combined use perfluorocarbon emulsions and multipotent mesenchymal stromal cells Download Download PDF